551. A Multistate Investigation of Serious Adverse Events, Including Deaths, Following Ceftriaxone Injections, September 2024–June 2025

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.024
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

551. A Multistate Investigation of Serious Adverse Events, Including Deaths, Following Ceftriaxone Injections, September 2024–June 2025

Shaina Bernard, Karen M. Landers, Andrea Flinchum, Christopher A. Czaja et al.
Open Forum Infectious Diseases
Pharmacovigilance and Adverse Drug Reactions
article

551. A Multistate Investigation of Serious Adverse Events, Including Deaths, Following Ceftriaxone Injections, September 2024–June 2025

Shaina Bernard, Karen M. Landers, Andrea Flinchum, Christopher A. Czaja, Mark Loh, Juliet Stoltey, Jenna N. Sinkevitch, Carolyn Hembree, Lauren Biehle, Jason Mehr, Brenda Brennan, Marco Tori, Trent Gulley, Maya Beganovic, Shannon B. Ruelle, Rachana Bhattarai, Cara Bicking Kinsey, Scott T. Harris, Rebecca Pierce, Kimberly K. Garner, Maribeth Sivilus, Ramesh Gopalaswamy, Stacy Tressler, Douglas Thoroughman, Christopher B. Wilson, Kelley Garner, Dat Tran, Malakai Miller, Allison G. Lafferty, Melanie Roderick, Argentina Charles, Simone Godwin, Melissa A Morrison, JoAnna Wagner, Shehzana Hussaini, Andrea Salinas, Joshua T Hoffner, Haley Beeman, Gargi Patel, Jennifer Lind Lyles, Grace Lee, Dumbani Kayira, Michael J Curran, B S Biochemistry, Andrew W Stubblefield, Riley Moore, Radhika Agarwal, Kiran M Perkins, Theresa Dulski, Cullen Adre, Liz Breitenstein
article en

Abstract

No abstract available for this paper.
Open Forum Infectious DiseasesVol. 13(Supplement_1)
South Carolina Department of Health and Environmental Control (US), Louisiana State Department of Health and Hospitals (US), Indiana University Health (US), Centers for Disease Control and Prevention (US), Arizona Department of Health Services (US), Alabama Department of Public Health (US), Michigan Department of Health and Human Services (US), Virginia Department of Health (US), Pennsylvania Department of Health (US), United States Food and Drug Administration (US), Florida Department of Health (US), Colorado Department of Public Health and Environment (US), California Department of Public Health (US), New Jersey Department of Health (US), Oregon Health Authority (US), Harris Health System (US), Vermont State Hospital (US), Indiana State Department of Health (US), Vermont Department of Mental Health (US), Centers for Disease Control and Prevention (UG), Clear Creek Independent School District (US), The Centers (US), Tennessee Department of Health (US), Vermont Department of Health (US), Connecticut Department of Public Health (US), Georgia Department of Public Health (US), Kentucky Department for Public Health (US), Centers for Disease Control and Prevention (KE), Food and Drug Administration (TH), Arkansas Department of Health (US)
Good health and well-being
Openalex Percentile: Top 91%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.